Outset Medical (OM) closed at $4.23 on November 6, 2026, up 3.2% from the previous close, on volume of 37,558 shares (30-day average 154,341).
Data as of November 6, 2026.
6-Nov-2026
Stifel Nicolaus Sticks to Its Buy Rating for Outset Medical (OM)
TipRanks (Thu, 5-Nov 4:47 PM ET)
Outset Medical (OM) Receives a Buy from TD Cowen
TipRanks (Thu, 5-Nov 9:07 AM ET)
RBC Capital Keeps Their Hold Rating on Outset Medical (OM)
TipRanks (Thu, 5-Nov 7:38 AM ET)
Outset Medical Non-GAAP EPS of -$0.68 beats by $0.01, revenue of $33.6M beats by $2.2M
Seeking Alpha News (Wed, 4-Nov 4:11 PM ET)
Outset Medical Reports Third Quarter 2026 Results
Globe Newswire (Wed, 4-Nov 4:01 PM ET)
Outset Medical Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 4-Nov 9:57 AM ET)
Outset Medical to Participate in the 2026 Stifel Healthcare Conference
Globe Newswire (Tue, 27-Oct 4:05 PM ET)
Outset Medical to Report Third Quarter 2026 Financial Results on Wednesday, November 4, 2026
Globe Newswire (Wed, 21-Oct 4:05 PM ET)
FDA Clearance for Next-Gen Tablo Hemodialysis Marks Major Milestone for Outset Medical
Market Chameleon (Tue, 27-Jan 4:33 AM ET)
Outset Medical Grows Revenue 5% and Lowers Cash Burn as Tablo Expands to Over 1,000 Sites
Market Chameleon (Mon, 12-Jan 4:54 AM ET)
Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
Outset Medical trades on the NASDAQ stock market under the symbol OM.
As of November 6, 2026, OM stock price climbed to $4.23 with 37,558 million shares trading.
OM has a beta of 1.97, meaning it tends to be more sensitive to market movements. OM has a correlation of 0.04 to the broad based SPY ETF.
OM has a market cap of $79.83 million. This is considered a Micro Cap stock.
Last quarter Outset Medical reported $34 million in Revenue and -$.68 earnings per share. This beat revenue expectation by $2 million and exceeded earnings estimates by $.04.
In the last 3 years, OM traded as high as $95.55 and as low as $2.84.
The top ETF exchange traded funds that OM belongs to (by Net Assets): VTI, VXF, DFAS, IWC, FMED.
OM has underperformed the market in the last year with a return of -64.2%, while the SPY ETF gained +10.8%. In the last 3 month period, OM fell short of the market, returning -18.7%, while SPY returned -4.1%. However, in the most recent 2 weeks OM has outperformed the stock market by returning +3.2%, while SPY returned -3.2%.
OM support price is $3.86 and resistance is $4.34 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OM shares will trade within this expected range on the day.